WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1992000990) INTERLEUKIN RECEPTOR EXPRESSION INHIBITING ANTISENSE OLIGONUCLEOTIDES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1992/000990    International Application No.:    PCT/US1991/004818
Publication Date: 23.01.1992 International Filing Date: 11.07.1991
Chapter 2 Demand Filed:    17.01.1992    
IPC:
A61K 9/127 (2006.01), C07H 21/00 (2006.01), C12N 15/11 (2006.01)
Applicants: NOVA PHARMACEUTICAL CORPORATION [US/US]; 6200 Freeport Centre, Baltimore, MD 21224-6522 (US)
Inventors: BURCH, Ronald, Martin; (US)
Agent: FABIANO, Vincent, L.; Nova Pharmaceutical Corporation, 6200 Freeport Centre, Baltimore, MD 21224-6522 (US)
Priority Data:
551,977 12.07.1990 US
Title (EN) INTERLEUKIN RECEPTOR EXPRESSION INHIBITING ANTISENSE OLIGONUCLEOTIDES
(FR) OLIGONUCLEOTIDES NON CODANTS INHIBANT L'EXPRESSION DES RECEPTEURS D'INTERLEUKINE
Abstract: front page image
(EN)Disclosed are oligonucleotide compounds that inhibit interleukin receptor expression when administered to a human subject. Also disclosed are pharmaceutical compositions and methods for inhibiting human interleukin receptor expression.
(FR)L'invention concerne des composés d'oligonucléotides qui inhibent l'expression des récepteurs d'interleukine lorsqu'on les administre à un être humain. Des compositions et des procédés pharmaceutiques servant à inhiber l'expression des récepteurs d'interleukine chez l'homme sont également décrits.
Designated States: CA, JP.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE).
Publication Language: English (EN)
Filing Language: English (EN)